151 related articles for article (PubMed ID: 19487658)
1. Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
Markovic-Plese S; Jewells V; Speer D
Neurology; 2009 Jun; 72(22):1965; author reply 1965-6. PubMed ID: 19487658
[No Abstract] [Full Text] [Related]
2. Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
Salvatore E; Morra VB; Orefice G
Neurology; 2009 Sep; 73(13):1078; author reply 1078-9. PubMed ID: 19786703
[No Abstract] [Full Text] [Related]
3. Atorvastatin does not alter interferon Beta-induced changes of serum matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in patients with multiple sclerosis.
Sellner J; Greeve I; Leib SL; Mattle HP
Arch Neurol; 2008 May; 65(5):672-4. PubMed ID: 18474748
[No Abstract] [Full Text] [Related]
4. Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack.
Mascitelli L; Pezzetta F; Goldstein MR; Chaturvedi S
Neurology; 2009 Jul; 73(3):249; author reply 249-50. PubMed ID: 19620618
[No Abstract] [Full Text] [Related]
5. Use of interferon-beta in the treatment of multiple sclerosis.
Derwenskus J; Lublin FD
Adv Neurol; 2006; 98():257-71. PubMed ID: 16400838
[No Abstract] [Full Text] [Related]
6. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study.
Goldstein MR; Mascitelli L; Pezzetta F
Neurology; 2009 Apr; 72(16):1448; author reply 1448-9. PubMed ID: 19380709
[No Abstract] [Full Text] [Related]
7. [The last round about statins: there is the fact that 80 mg simvastatin daily results in high risk of myopathy].
Olsson AG
Lakartidningen; 2009 Oct 21-27; 106(43):2783-4; author reply 2784. PubMed ID: 19960911
[No Abstract] [Full Text] [Related]
8. [Results of randomized study: intensive lipid lowering treatment stops coronary atherosclerosis].
MMW Fortschr Med; 2004 Mar; 146(13):64-5. PubMed ID: 15219142
[No Abstract] [Full Text] [Related]
9. Atorvastatin.
Hyatt PJ
Br J Hosp Med; 1997 Oct 1-14; 58(7):333-6. PubMed ID: 9509055
[No Abstract] [Full Text] [Related]
10. Interferon neutralizing antibodies in multiple sclerosis: a new perspective.
Phillips JT
Arch Neurol; 2010 Apr; 67(4):386-7. PubMed ID: 20385901
[No Abstract] [Full Text] [Related]
11. Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy.
Lanzillo R; Orefice G; Quarantelli M; Rinaldi C; Prinster A; Ventrella G; Spitaleri D; Lus G; Vacca G; Carotenuto B; Salvatore E; Brunetti A; Tedeschi G; Brescia Morra V
Mult Scler; 2010 Apr; 16(4):450-4. PubMed ID: 20150398
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effect of statins in multiple sclerosis: is it dose-dependent?
Sena A; Pedrosa R; Morais MG
Atherosclerosis; 2007 Apr; 191(2):462. PubMed ID: 17007861
[No Abstract] [Full Text] [Related]
13. Aggressive low-density lipoprotein cholesterol lowering in secondary prevention of coronary heart disease.
Clearfield M
Curr Atheroscler Rep; 2006 Jan; 8(1):7-8. PubMed ID: 16455005
[No Abstract] [Full Text] [Related]
14. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
Paradis JM; LeLorier J
N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309744
[No Abstract] [Full Text] [Related]
15. Effects of atorvastatin 80 mg daily early after onset of unstable angina pectoris or non-Q-wave myocardial infarction.
Colivicchi F; Guido V; Tubaro M; Ammirati F; Montefoschi N; Varveri A; Santini M
Am J Cardiol; 2002 Oct; 90(8):872-4. PubMed ID: 12372577
[No Abstract] [Full Text] [Related]
16. Amlodipine/atorvastatin fixed-dose combination: a review of its use in the prevention of cardiovascular disease and in the treatment of hypertension and dyslipidemia.
McKeage K; Siddiqui MA
Am J Cardiovasc Drugs; 2008; 8(1):51-67. PubMed ID: 18303938
[TBL] [Abstract][Full Text] [Related]
17. Coming of age: the use of immunomodulatory therapy in children with multiple sclerosis.
Banwell B; Tremlett H
Neurology; 2005 Mar; 64(5):778-9. PubMed ID: 15753408
[No Abstract] [Full Text] [Related]
18. Generic atorvastatin-induced thrombocytopenic purpura: a raised red flag.
Gurevich A; Epstein L; Stein GY
Isr Med Assoc J; 2013 Mar; 15(3):197-8. PubMed ID: 23662392
[No Abstract] [Full Text] [Related]
19. Binder wars.
Martinez DG
Am J Kidney Dis; 2008 Nov; 52(5):1024; author reply 1025. PubMed ID: 18971020
[No Abstract] [Full Text] [Related]
20. [Statins: for the time being, do not as a rule prescribe the maximum dose].
Smulders YM
Ned Tijdschr Geneeskd; 2005 Aug; 149(34):1876-8. PubMed ID: 16136739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
